UK Markets open in 2 hrs 27 mins
  • NIKKEI 225

    27,560.31
    -81.52 (-0.29%)
     
  • HANG SENG

    26,605.79
    +410.97 (+1.57%)
     
  • CRUDE OIL

    70.45
    -0.11 (-0.16%)
     
  • GOLD FUTURES

    1,816.00
    +1.90 (+0.10%)
     
  • DOW

    35,116.40
    +278.24 (+0.80%)
     
  • BTC-GBP

    27,177.37
    -788.04 (-2.82%)
     
  • CMC Crypto 200

    925.64
    -17.81 (-1.89%)
     
  • Nasdaq

    14,761.29
    +80.23 (+0.55%)
     
  • ^FTAS

    4,074.79
    +13.67 (+0.34%)
     

Global qPCR and dPCR Instrumentation Market to Reach $9.2 Billion by 2026

·24-min read

Abstract: Global qPCR and dPCR Instrumentation Market to Reach $9. 2 Billion by 2026 . - Real-Time PCR also referred to as Quantitative PCR (qPCR) analysis, is a modification of the traditional PCR technique.

New York, June 24, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global qPCR and dPCR Instrumentation Industry" - https://www.reportlinker.com/p01921269/?utm_source=GNW
In traditional Polymerase Chain Reaction (PCR), the amplified DNA product or amplicon is detected in an end-point analysis by visualization of the DNA product on an agarose gel subsequent to completion of the reaction, which comprises a specified number of amplification cycles. In real-time PCR, however, the accumulation of amplification product is evaluated simultaneously with the progress of the reaction. Product quantification is carried out in real time, after every cycle. Digital PCR (dPCR) is an improvement of traditional PCR methods and is utilized to directly quantify as well as clonally amplify nucleic acids such as DNA, RNA, cDNA or methylated DNA. However, digital PCR is at an early stage. The main difference between conventional PCR and dPCR lies in the method used to measure amounts of nucleic acids. Sensitivity of dPCR is high in comparison to qPCR, hence, the technology is particularly used in applications wherein there is a low amount of target sequence. For instance, mutation genes that are found on a very low scale in rare diseases, and HIV DNA that are present in 1,000-10,000 in number within the cell of a patient can be easily detected through the technology.

- Amid the COVID-19 crisis, the global market for qPCR and dPCR Instrumentation estimated at US$5.2 Billion in the year 2020, is projected to reach a revised size of US$9.2 Billion by 2026, growing at a CAGR of 9.8% over the analysis period. qPCR, one of the segments analyzed in the report, is projected to grow at a 9.3% CAGR to reach US$8.4 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the dPCR segment is readjusted to a revised 13% CAGR for the next 7-year period. This segment currently accounts for a 12.5% share of the global qPCR and dPCR Instrumentation market.

The U.S. Market is Estimated at $1.9 Billion in 2021, While China is Forecast to Reach $742.3 Million by 2026

- The qPCR and dPCR Instrumentation market in the U.S. is estimated at US$1.9 Billion in the year 2021. The country currently accounts for a 30.8% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$742.3 Million in the year 2026 trailing a CAGR of 12.2% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.1% and 8.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR while Rest of European market (as defined in the study) will reach US$813.9 Million by the close of the analysis period.

- While Europe is another large market for qPCR and dPCR instrumentation, growth worldwide is projected to be spearheaded by Asia-Pacific. In terms of concentration, a large number of leading companies are located in the US and Europe. However, increasing competition in the markets over the last few years has been driving various players to shift their attention to other promising regions including Latin America and Asia-Pacific. In Asia-Pacific, growth is led by the increased use of qPCR in blood donor testing & screening and diagnosis of infectious diseases and tropical diseases such as Malaria. Increasing geriatric population and the resulting incidents of chronic medical conditions such as cancer coupled with broader application of PCR to study mutations and gene anomalies related to these diseases are driving adoption. Falling cost of nucleic acid detection, quantification, and amplification techniques will additionally encourage adoption of qPCR and dPCR instrumentation in research and diagnosis, particularly in developing, resource poor countries. Asia-Pacific has been witnessing increasing focus of PCR solution suppliers to establish or expand their production and sales network in the region. In the recent years, various vendors have shifted their manufacturing units to the region for enjoying cost benefits and accessing domestic markets, which in turn is increasing awareness of the technology in the region, contributing to growth in the market.
Select Competitors (Total 74 Featured)

  • Agilent Technologies, Inc.

  • Becton, Dickinson and Company

  • BioFire Diagnostics, Inc.

  • Bio-Rad Laboratories, Inc.

  • Cepheid

  • Eppendorf AG

  • F. Hoffmann-La Roche Ltd.

  • Fluidigm Corporation

  • Promega Corporation

  • QIAGEN N.V.

  • RainDance Technologies, Inc.

  • Takara Bio, Inc.

  • Thermo Fischer Scientific Inc.




Read the full report: https://www.reportlinker.com/p01921269/?utm_source=GNW

CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Polymerase Chain Reaction (PCR): An Integral Part of Gene
Amplification & Quantification
Impact of Covid-19 and a Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual
% Change) for 2019 to 2022
Impact of COVID-19 on Clinical Diagnostics Sector
Emergence of PCR as a Preferred COVID-19 Detection Method
Performance Analysis of COVID-19 Tests
EXHIBIT 2: Total Number of COVID-19 Tests Conducted in the Most
Impacted Countries: As of January 13th, 2021
Molecular Tests (RT-PCR) Occupy a Predominant Share of the
COVID-19 Testing Market
EXHIBIT 3: Global COVID-19 Testing Market Breakdown by Testing
Type: 2020 and 2027
Select Approved Covid-19 Molecular Assay Tests
Recent PCR Based Tests
Digital PCR Sparks Increasing Interest
High-Speed NanoPCR Technology Developed for Point-of-Care
Diagnosis of COVID-19
CRISPR Emerges as Cutting-Edge Biotechnology in COVID-19
Diagnostic Market
Demand for PCR Testing to Remain Buoyant in 2021
Real-Time PCR and Digital PCR: Scope and Definition
Real-Time PCR or Quantitative PCR (qPCR)
qPCR Instrumentation
Disadvantages
Advantages of qPCR
End-Use Applications of qPCR
Digital PCR (dPCR)
Working Principle
Applications of dPCR
Advantages of dPCR
qPCR Remains the Mainstay Technology
Digital PCR to Experience Strong Growth
High Installation Cost Remains a Roadblock to Widespread
Adoption of dPCR
Developing Countries Drive Growth Opportunities
Competition
Competitive Factors
Accelerated Commercialization of Products
Manufacturers Step-Up Online Exposure
Targeted Expansion of Distribution Reach and Global Footprint
Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Striking the Right Balance between qPCR and dPCR in Research
Laboratories
qPCR: A Suitable Tool for Gene Expression and Validation
Digital PCR Takes Quantification of Nucleic Acids to the Next
Level
dPCR: A Valuable Tool in Virology Research
Increasing Incidence and Prevalence of Cancer: A Grim Reality
Driving Demand for qPCR and dPCR
EXHIBIT 4: Global Cancer Incidence: Number of New Cancer Cases
in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
EXHIBIT 5: Breakdown of Total Number of Cancer Cases by Region:
2020
EXHIBIT 6: Breakdown of Total Number of Cancer Cases by Type: 2020
dPCR for Analyzing Hematologic Malignancies
dPCR for Liquid Biopsies
Progress in Molecular Diagnostics Spur Demand for the Gene
Amplification Technologies
Prospects for Predictive Genetic Diagnostics and Testing Grow
Brighter
EXHIBIT 7: Global Prenatal Diagnostics Market in US$ Billion:
2015 and 2022
EXHIBIT 8: Global Genetic Testing Market in US$ Billion: 2020
and 2027
Rise in Infectious Diseases Drives Opportunities for Biochips
EXHIBIT 9: Infectious Diseases Remain Major Cause of Death in
Under Developed Regions: Breakdown of Leading Causes of Death
in Sub-Saharan Africa (in %)
EXHIBIT 10: Infectious Diseases Related Mortality High Among
Children Below 5 Years: Breakdown of Leading Causes of Death
in Children Below 5 Years (in %)
Innovations in Instrumentation Expand Functionality and Drive
Adoption
Advancements in Probe Technology Enhance qPCR Sensitivity
qPCR Market to Witness Increasing Affinity for Automated and
Robotic Equipment
Lab on Chip/Microfluidic Real-time-PCR
Synoptic Review of Quantitative PCR Technical Advancements in
the Recent Years
ddPCR: The More Advanced Digital Approach to dPCR
ddPCR Gains Traction in Cancer Diagnosis
Monitoring Disease Progression in HIV Studies
EXHIBIT 11: Global HIV Prevalence: Number of People Living with
AIDs (in Thousands) by Region for 2018
Analysis of Genetically Modified Organisms in Edible Products
RT-ddPCR Techniques Applied for Quantitating RNA Viruses in
Water Samples
Technology Advancements Aid in Overcoming Barriers
Alternate Technologies Pose Threat to Growth of PCR Market
Next-Generation Sequencing to Emerge as Novel Technique in
Fight with COVID-19
Improving Healthcare Expenditure to Drive Demand for qPCR and
dPCR-based Tests
EXHIBIT 12: World Healthcare Expenditure (In US$ Billion) for
the Years 2017-2023
PCR in Forensic and Paternity Testing

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for qPCR and dPCR
Instrumentation by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for qPCR and dPCR
Instrumentation by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for qPCR and dPCR
Instrumentation by Geographic Region - Percentage Breakdown of
Value Revenues for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for qPCR by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2020 through 2027
and % CAGR

Table 5: World Historic Review for qPCR by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for qPCR by Geographic
Region - Percentage Breakdown of Value Revenues for USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for dPCR by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2020 through 2027
and % CAGR

Table 8: World Historic Review for dPCR by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for dPCR by Geographic
Region - Percentage Breakdown of Value Revenues for USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Reagents &
Consumables by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Reagents & Consumables by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Reagents & Consumables
by Geographic Region - Percentage Breakdown of Value Revenues
for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Instruments by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Instruments by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2012 through 2019
and % CAGR

Table 15: World 15-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Software &
Services by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Software & Services by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Software & Services by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Hospitals &
Diagnostic Centers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Hospitals & Diagnostic
Centers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Hospitals & Diagnostic
Centers by Geographic Region - Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 22: World Current & Future Analysis for Research
Laboratories & Academic Institutes by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Research Laboratories &
Academic Institutes by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Research Laboratories &
Academic Institutes by Geographic Region - Percentage Breakdown
of Value Revenues for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 25: World Current & Future Analysis for Pharma & Biotech
Companies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for Pharma & Biotech Companies
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Pharma & Biotech
Companies by Geographic Region - Percentage Breakdown of Value
Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 28: World Current & Future Analysis for Clinical Research
Organizations by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 29: World Historic Review for Clinical Research
Organizations by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Clinical Research
Organizations by Geographic Region - Percentage Breakdown of
Value Revenues for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 31: World Current & Future Analysis for Forensic
Laboratories by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 32: World Historic Review for Forensic Laboratories by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 33: World 15-Year Perspective for Forensic Laboratories
by Geographic Region - Percentage Breakdown of Value Revenues
for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 34: USA Current & Future Analysis for qPCR and dPCR
Instrumentation by Classification - qPCR and dPCR - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 35: USA Historic Review for qPCR and dPCR Instrumentation
by Classification - qPCR and dPCR Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2012
through 2019 and % CAGR

Table 36: USA 15-Year Perspective for qPCR and dPCR
Instrumentation by Classification - Percentage Breakdown of
Value Revenues for qPCR and dPCR for the Years 2012, 2020 &
2027

Table 37: USA Current & Future Analysis for qPCR and dPCR
Instrumentation by Component - Reagents & Consumables,
Instruments and Software & Services - Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 38: USA Historic Review for qPCR and dPCR Instrumentation
by Component - Reagents & Consumables, Instruments and Software &
Services Markets - Independent Analysis of Annual Revenues in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 39: USA 15-Year Perspective for qPCR and dPCR
Instrumentation by Component - Percentage Breakdown of Value
Revenues for Reagents & Consumables, Instruments and Software &
Services for the Years 2012, 2020 & 2027

Table 40: USA Current & Future Analysis for qPCR and dPCR
Instrumentation by End-Use - Hospitals & Diagnostic Centers,
Research Laboratories & Academic Institutes, Pharma & Biotech
Companies, Clinical Research Organizations and Forensic
Laboratories - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 41: USA Historic Review for qPCR and dPCR Instrumentation
by End-Use - Hospitals & Diagnostic Centers, Research
Laboratories & Academic Institutes, Pharma & Biotech Companies,
Clinical Research Organizations and Forensic Laboratories
Markets - Independent Analysis of Annual Revenues in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 42: USA 15-Year Perspective for qPCR and dPCR
Instrumentation by End-Use - Percentage Breakdown of Value
Revenues for Hospitals & Diagnostic Centers, Research
Laboratories & Academic Institutes, Pharma & Biotech Companies,
Clinical Research Organizations and Forensic Laboratories for
the Years 2012, 2020 & 2027

CANADA
Table 43: Canada Current & Future Analysis for qPCR and dPCR
Instrumentation by Classification - qPCR and dPCR - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 44: Canada Historic Review for qPCR and dPCR
Instrumentation by Classification - qPCR and dPCR Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 45: Canada 15-Year Perspective for qPCR and dPCR
Instrumentation by Classification - Percentage Breakdown of
Value Revenues for qPCR and dPCR for the Years 2012, 2020 &
2027

Table 46: Canada Current & Future Analysis for qPCR and dPCR
Instrumentation by Component - Reagents & Consumables,
Instruments and Software & Services - Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 47: Canada Historic Review for qPCR and dPCR
Instrumentation by Component - Reagents & Consumables,
Instruments and Software & Services Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2012
through 2019 and % CAGR

Table 48: Canada 15-Year Perspective for qPCR and dPCR
Instrumentation by Component - Percentage Breakdown of Value
Revenues for Reagents & Consumables, Instruments and Software &
Services for the Years 2012, 2020 & 2027

Table 49: Canada Current & Future Analysis for qPCR and dPCR
Instrumentation by End-Use - Hospitals & Diagnostic Centers,
Research Laboratories & Academic Institutes, Pharma & Biotech
Companies, Clinical Research Organizations and Forensic
Laboratories - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 50: Canada Historic Review for qPCR and dPCR
Instrumentation by End-Use - Hospitals & Diagnostic Centers,
Research Laboratories & Academic Institutes, Pharma & Biotech
Companies, Clinical Research Organizations and Forensic
Laboratories Markets - Independent Analysis of Annual Revenues
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 51: Canada 15-Year Perspective for qPCR and dPCR
Instrumentation by End-Use - Percentage Breakdown of Value
Revenues for Hospitals & Diagnostic Centers, Research
Laboratories & Academic Institutes, Pharma & Biotech Companies,
Clinical Research Organizations and Forensic Laboratories for
the Years 2012, 2020 & 2027

JAPAN
Table 52: Japan Current & Future Analysis for qPCR and dPCR
Instrumentation by Classification - qPCR and dPCR - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 53: Japan Historic Review for qPCR and dPCR
Instrumentation by Classification - qPCR and dPCR Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 54: Japan 15-Year Perspective for qPCR and dPCR
Instrumentation by Classification - Percentage Breakdown of
Value Revenues for qPCR and dPCR for the Years 2012, 2020 &
2027

Table 55: Japan Current & Future Analysis for qPCR and dPCR
Instrumentation by Component - Reagents & Consumables,
Instruments and Software & Services - Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 56: Japan Historic Review for qPCR and dPCR
Instrumentation by Component - Reagents & Consumables,
Instruments and Software & Services Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2012
through 2019 and % CAGR

Table 57: Japan 15-Year Perspective for qPCR and dPCR
Instrumentation by Component - Percentage Breakdown of Value
Revenues for Reagents & Consumables, Instruments and Software &
Services for the Years 2012, 2020 & 2027

Table 58: Japan Current & Future Analysis for qPCR and dPCR
Instrumentation by End-Use - Hospitals & Diagnostic Centers,
Research Laboratories & Academic Institutes, Pharma & Biotech
Companies, Clinical Research Organizations and Forensic
Laboratories - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 59: Japan Historic Review for qPCR and dPCR
Instrumentation by End-Use - Hospitals & Diagnostic Centers,
Research Laboratories & Academic Institutes, Pharma & Biotech
Companies, Clinical Research Organizations and Forensic
Laboratories Markets - Independent Analysis of Annual Revenues
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 60: Japan 15-Year Perspective for qPCR and dPCR
Instrumentation by End-Use - Percentage Breakdown of Value
Revenues for Hospitals & Diagnostic Centers, Research
Laboratories & Academic Institutes, Pharma & Biotech Companies,
Clinical Research Organizations and Forensic Laboratories for
the Years 2012, 2020 & 2027

CHINA
Table 61: China Current & Future Analysis for qPCR and dPCR
Instrumentation by Classification - qPCR and dPCR - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 62: China Historic Review for qPCR and dPCR
Instrumentation by Classification - qPCR and dPCR Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 63: China 15-Year Perspective for qPCR and dPCR
Instrumentation by Classification - Percentage Breakdown of
Value Revenues for qPCR and dPCR for the Years 2012, 2020 &
2027

Table 64: China Current & Future Analysis for qPCR and dPCR
Instrumentation by Component - Reagents & Consumables,
Instruments and Software & Services - Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 65: China Historic Review for qPCR and dPCR
Instrumentation by Component - Reagents & Consumables,
Instruments and Software & Services Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2012
through 2019 and % CAGR

Table 66: China 15-Year Perspective for qPCR and dPCR
Instrumentation by Component - Percentage Breakdown of Value
Revenues for Reagents & Consumables, Instruments and Software &
Services for the Years 2012, 2020 & 2027

Table 67: China Current & Future Analysis for qPCR and dPCR
Instrumentation by End-Use - Hospitals & Diagnostic Centers,
Research Laboratories & Academic Institutes, Pharma & Biotech
Companies, Clinical Research Organizations and Forensic
Laboratories - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 68: China Historic Review for qPCR and dPCR
Instrumentation by End-Use - Hospitals & Diagnostic Centers,
Research Laboratories & Academic Institutes, Pharma & Biotech
Companies, Clinical Research Organizations and Forensic
Laboratories Markets - Independent Analysis of Annual Revenues
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 69: China 15-Year Perspective for qPCR and dPCR
Instrumentation by End-Use - Percentage Breakdown of Value
Revenues for Hospitals & Diagnostic Centers, Research
Laboratories & Academic Institutes, Pharma & Biotech Companies,
Clinical Research Organizations and Forensic Laboratories for
the Years 2012, 2020 & 2027

EUROPE
Table 70: Europe Current & Future Analysis for qPCR and dPCR
Instrumentation by Geographic Region - France, Germany, Italy,
UK, Spain, Russia and Rest of Europe Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2020
through 2027 and % CAGR

Table 71: Europe Historic Review for qPCR and dPCR
Instrumentation by Geographic Region - France, Germany, Italy,
UK, Spain, Russia and Rest of Europe Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2012
through 2019 and % CAGR

Table 72: Europe 15-Year Perspective for qPCR and dPCR
Instrumentation by Geographic Region - Percentage Breakdown of
Value Revenues for France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets for Years 2012, 2020 & 2027

Table 73: Europe Current & Future Analysis for qPCR and dPCR
Instrumentation by Classification - qPCR and dPCR - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 74: Europe Historic Review for qPCR and dPCR
Instrumentation by Classification - qPCR and dPCR Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 75: Europe 15-Year Perspective for qPCR and dPCR
Instrumentation by Classification - Percentage Breakdown of
Value Revenues for qPCR and dPCR for the Years 2012, 2020 &
2027

Table 76: Europe Current & Future Analysis for qPCR and dPCR
Instrumentation by Component - Reagents & Consumables,
Instruments and Software & Services - Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 77: Europe Historic Review for qPCR and dPCR
Instrumentation by Component - Reagents & Consumables,
Instruments and Software & Services Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2012
through 2019 and % CAGR

Table 78: Europe 15-Year Perspective for qPCR and dPCR
Instrumentation by Component - Percentage Breakdown of Value
Revenues for Reagents & Consumables, Instruments and Software &
Services for the Years 2012, 2020 & 2027

Table 79: Europe Current & Future Analysis for qPCR and dPCR
Instrumentation by End-Use - Hospitals & Diagnostic Centers,
Research Laboratories & Academic Institutes, Pharma & Biotech
Companies, Clinical Research Organizations and Forensic
Laboratories - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 80: Europe Historic Review for qPCR and dPCR
Instrumentation by End-Use - Hospitals & Diagnostic Centers,
Research Laboratories & Academic Institutes, Pharma & Biotech
Companies, Clinical Research Organizations and Forensic
Laboratories Markets - Independent Analysis of Annual Revenues
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 81: Europe 15-Year Perspective for qPCR and dPCR
Instrumentation by End-Use - Percentage Breakdown of Value
Revenues for Hospitals & Diagnostic Centers, Research
Laboratories & Academic Institutes, Pharma & Biotech Companies,
Clinical Research Organizations and Forensic Laboratories for
the Years 2012, 2020 & 2027

FRANCE
Table 82: France Current & Future Analysis for qPCR and dPCR
Instrumentation by Classification - qPCR and dPCR - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 83: France Historic Review for qPCR and dPCR
Instrumentation by Classification - qPCR and dPCR Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 84: France 15-Year Perspective for qPCR and dPCR
Instrumentation by Classification - Percentage Breakdown of
Value Revenues for qPCR and dPCR for the Years 2012, 2020 &
2027

Table 85: France Current & Future Analysis for qPCR and dPCR
Instrumentation by Component - Reagents & Consumables,
Instruments and Software & Services - Independent Analysis of
Annual Revenues in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 86: France Historic Review for qPCR and dPCR
Instrumentation by Component - Reagents & Consumables,
Instruments and Software & Services Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2012
through 2019 and % CAGR

Table 87: France 15-Year Perspective for qPCR and dPCR
Instrumentation by Component - Percentage Breakdown of Value
Revenues for Reagents & Consumables, Instruments and Software &
Services for the Years 2012, 2020 & 2027

Table 88: France Current & Future Analysis for qPCR and dPCR
Instrumentation by End-Use - Hospitals & Diagnostic Centers,
Research Laboratories & Academic Institutes, Pharma & Biotech
Companies, Clinical Research Organizations and Forensic
Laboratories - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 89: France Historic Review for qPCR and dPCR
Instrumentation by End-Use - Hospitals & Diagnostic Centers,
Research Laboratories & Academic Institutes, Pharma & Biotech
Companies, Clinical Research Organizations and Forensic
Laboratories Markets - Independent Analysis of Annual Revenues
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 90: France 15-Year Perspective for qPCR and dPCR
Instrumentation by End-Use - Percentage Breakdown of Value
Revenues for Hospitals & Diagnostic Centers, Research
Laboratories & Academic Institutes, Pharma & Biotech Companies,
Clinical Research Organizations and Forensic Laboratories for
the Years 2012, 2020 & 2027

GERMANY
Table 91: Germany Current & Future Analysis for qPCR and dPCR
Instrumentation by Classification - qPCR and dPCR - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2020
through 2027 and % CAGR

Read the full report: https://www.reportlinker.com/p01921269/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting